These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 9826983
1. Traditional pharmacological treatments for spasticity. Part I: Local treatments. Gracies JM, Elovic E, McGuire J, Simpson DM. Muscle Nerve Suppl; 1997; 6():S61-91. PubMed ID: 9826983 [Abstract] [Full Text] [Related]
2. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Gracies JM, Nance P, Elovic E, McGuire J, Simpson DM. Muscle Nerve Suppl; 1997; 6():S92-120. PubMed ID: 9826984 [Abstract] [Full Text] [Related]
7. Botulinum toxin in the management of spasticity in adults. Turner-Stokes L, Ward A. Clin Med (Lond); 2002 Jul; 2(2):128-30. PubMed ID: 11991094 [Abstract] [Full Text] [Related]
8. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin. Koman LA, Paterson Smith B, Balkrishnan R. Paediatr Drugs; 2003 Jul; 5(1):11-23. PubMed ID: 12513103 [Abstract] [Full Text] [Related]
9. Mechanisms of action of phenol block and botulinus toxin Type A in relieving spasticity: electrophysiologic investigation and follow-up. On AY, Kirazli Y, Kismali B, Aksit R. Am J Phys Med Rehabil; 1999 Jul; 78(4):344-9. PubMed ID: 10418840 [Abstract] [Full Text] [Related]
10. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment. Sheean G. Drug Saf; 2006 Jul; 29(1):31-48. PubMed ID: 16454533 [Abstract] [Full Text] [Related]
11. Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Spasticity Study Group. Brin MF. Muscle Nerve Suppl; 1997 Jul; 6():S208-20. PubMed ID: 9826992 [Abstract] [Full Text] [Related]
12. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group]. Wissel J, Müller J, Heinen F, Mall V, Sojer M, Ebersbach G, Poewe W. Wien Klin Wochenschr; 1999 Oct 29; 111(20):837-42. PubMed ID: 10586488 [Abstract] [Full Text] [Related]
13. Interest of peripheral anesthetic blocks as a diagnosis and prognosis tool in patients with spastic equinus foot: a clinical and electrophysiological study of the effects of block of nerve branches to the triceps surae muscle. Buffenoir K, Decq P, Lefaucheur JP. Clin Neurophysiol; 2005 Jul 29; 116(7):1596-600. PubMed ID: 15905125 [Abstract] [Full Text] [Related]
14. [Alcohol neurolytic blocks for pain and muscle spasticity]. Viel E, Pelissier J, Pellas F, Boulay C, Eledjam JJ. Neurochirurgie; 2003 May 29; 49(2-3 Pt 2):256-62. PubMed ID: 12746700 [Abstract] [Full Text] [Related]
16. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients. Pullman SL, Greene P, Fahn S, Pedersen SF. Arch Neurol; 1996 Jul 29; 53(7):617-24. PubMed ID: 8929169 [Abstract] [Full Text] [Related]
17. [Interest of anesthetic blocks for assessment of the spastic patient. A series of 815 motor blocks]. Filipetti P, Decq P. Neurochirurgie; 2003 May 29; 49(2-3 Pt 2):226-38. PubMed ID: 12746697 [Abstract] [Full Text] [Related]
20. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study. Buyukavci R, Akturk S, Ersoy Y. Eur J Phys Rehabil Med; 2018 Oct 29; 54(5):738-744. PubMed ID: 29422486 [Abstract] [Full Text] [Related] Page: [Next] [New Search]